Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim)
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Pittsburgh, Northern California Melanoma Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596519715
